九安醫療(002432.SZ):擬購買控股子公司少數股東股權
格隆匯2月12日丨九安醫療(002432.SZ)公佈,經小米投資與公司協商,九安控股全資子公司AndonHongKongCo.,Limited(簡稱:“九安香港”)擬與BestVenturesLimited(原名:XiaomiVenturesLimited,簡稱“小米投資”)簽署《股權轉讓協議》,小米投資將所持有的iHealthInc.20%的股權以45,910,455美元全部轉讓,交易定價參照少數股東權益賬面價值並經雙方協商,該交易價格公允、合理。股權轉讓完成後,公司對iHealthInc.的合併持股比例由80%增加至100%,繼續納入公司合併報表範圍。近年來,iHealth體系子公司緊密圍繞公司“爆款產品”及加速推動糖尿病診療照護“O+O”新模式在中國、美國的落地兩大核心戰略,業務不斷拓展。隨着試劑盒產品在美國被廣泛使用,iHealth品牌在當地家用醫療健康產品市場的知名度和影響力顯著增強,積累了良好的用戶口碑。本次交易完成後,有助於進一步支持iHealth體系子公司的發展,加強對子公司的控制權。相關協議的簽署,不會以任何方式修改、更改或以其他方式改變九安公司、小米集團及其各自分支機構之間當前的合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.